Oxcarbazepine Tablet, Film Coated
Product Images NDC 63629-3816

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-3816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl636293816

Lbl636293816
This appears to be a product label for a medication called Trileptal 150MG Tablet. It includes information about the manufacturer (Nexgen Pharma, Inc.), package details (#30 EXP MM/YY, NDC number), and instructions for storage and keeping the drug out of reach of children. The label also includes a barcode.*
FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Chemical Structure (Oxcarbazepine 02)

Chemical Structure (Oxcarbazepine 02)
The text describes statistical test results for the "Exit rate" with a p-value of 0.0001. There is also a plot showing the "Time on trial" for Placebo from Day 2 to Day 11.*
FDA Label Image

Chemical Structure (Oxcarbazepine 03)

Chemical Structure (Oxcarbazepine 03)
This is a graph that represents the seizure rate of two groups of patients over a period of 140 days. The treatment group was given oxcarbazepine and the control group was given a placebo. The log-rank test suggests a statistically significant difference between the two groups with a p-value of 0.046. The X-axis shows the days from the first dose to the first seizure and the Y-axis is not provided.*
FDA Label Image

Chemical Structure (Oxcarbazepine 04)

Chemical Structure (Oxcarbazepine 04)
This text is displaying results of a log-rank test and a graph showing the time to exit for a treatment group. It is not possible to provide a further description without additional context or information.*
FDA Label Image

Chemical Structure (Oxcarbazepine 05)

Chemical Structure (Oxcarbazepine 05)
The text describes the results of a log-rank test with a p-value of 0.0001, but the context of the analysis is not given. The graph shows the time to exit in days for a treatment group designated as "HIGH" and a comparison group designated as "LOW" at various time points up to 130 days.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.